Metabolic syndrome; associations with adverse outcome after colorectal surgery. A systematic review and meta-analysis

Reudink, Muriël; Slooter, C.D.; Janssen, Loes; Lieverse, Aloysius G.; Roumen, R. M. H.; Slooter, Gerrit D.

doi:10.1016/j.amsu.2021.102997

Cited by 8 publications

(2 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This syndrome is a cluster of risk factors that can lead to developing chronic conditions, such as cardiovascular disease. In a recent systematic review on colorectal surgery, patients with metabolic syndrome were more likely to develop severe complications, which is in accordance with the findings in the present study [ 22 ]. Moreover, patients in our study with lower BMI and weight had a higher risk of severe complications.…”

Section: Discussionsupporting

confidence: 93%

Same-Day Discharge After Laparoscopic Roux-en-Y Gastric Bypass: a Cohort of 500 Consecutive Patients

et al. 2023

View full text Add to dashboard Cite

Introduction There is an increasing demand on hospital capacity worldwide due to the COVID-19 pandemic and local staff shortages. Novel care pathways have to be developed in order to keep bariatric and metabolic surgery maintainable. Same-day discharge (SDD) after laparoscopic Roux-en-Y gastric bypass (RYGB) is proved to be feasible and could potentially solve this challenge. The aim of this study was to investigate whether SDD after RYGB is safe for a selected group of patients. Methods In this single-center cohort study, low-risk patients were selected for primary RYGB with intended same-day discharge with remote monitoring. All patients were operated according to ERAS protocol. There were strict criteria on approval upon same-day discharge. It was demanded that patients should contact the hospital in case of any signs of complications. Primary outcome was the rate of successful same-day discharge without readmission within 48 h. Secondary outcomes included short-term complications, emergency department visits, readmissions, and mortality. Results Five hundred patients underwent RYGB with intended SDD, of whom 465 (93.0%) were successfully discharged. Twenty-one patients (4.5%) were readmitted in the first 48 h postoperatively. None of these patients had a severe bleeding. This results in a success rate of 88.8% of SDD without readmission within 48 h. Conclusions Same-day discharge after RYGB is safe, provided that patients are carefully selected and strict discharge criteria are used. It is an effective care pathway to reduce the burden on hospital capacity. Graphical Abstract

show abstract

Section: Discussionsupporting

confidence: 93%

Same-Day Discharge After Laparoscopic Roux-en-Y Gastric Bypass: a Cohort of 500 Consecutive Patients

et al. 2023

View full text Add to dashboard Cite

show abstract

“…These findings are similar to findings of previous studies in patients with digestive system malignancies of other sites. An early meta-analysis included six studies and showed that MetS may have a negative impact on adverse outcome after colorectal surgery, such as the increased risk of anastomotic leakage [ 28 ]. A more recent meta-analysis in patients with gastric cancer also showed that MetS was associated with higher risks of postoperative complications [ 29 ].…”

Section: Discussionmentioning

confidence: 99%

Influence of metabolic syndrome on prognosis of patients with surgically treated esophageal cancer: a meta-analysis

Zhang,

Huang,

2024

Diabetol Metab Syndr

View full text Add to dashboard Cite

Background Metabolic syndrome (MetS) has been related to the increased incidence of esophageal cancer (EC). The aim of the study was to evaluate the influence of MetS on prognosis of patients with surgically treated EC in a systematic review and meta-analysis. Methods An extensive search was conducted on PubMed, Embase, Web of Science, Wanfang, and CNKI to identify relevant cohort studies. Random-effects models were employed to combine the findings, taking into account the potential influence of heterogeneity. Results Seven cohort studies involving 4332 patients with stage I-III EC who received surgical resection were included. At baseline, 608 (14.0%) patients had MetS. Pooled results suggested that MetS were associated with a higher risk of postoperative complications (risk ratio [RR]: 1.30, 95% confidence interval [CI]: 1.03 to 1.64, p = 0.03; I2 = 0%). However, the overall survival (RR: 1.07, 95% CI: 0.75 to 1.52, p = 0.71; I2 = 80%) and progression-free survival (RR: 1.27, 95% CI: 0.53 to 3.00, p = 0.59; I2 = 80%) were not significantly different between patients with and without MetS. Subgroup analyses suggested that the results were not significantly modified by study design (prospective or retrospective), histological type of EC (squamous cell carcinoma or adenocarcinoma), or diagnostic criteria for MetS (p values indicating subgroup difference all > 0.05). Conclusion Although MetS may be associated with a moderately increased risk of postoperative complications in patients with EC under surgical resection, the long-term survival may not be different between patients with and without MetS.

show abstract

Impact of type 2 diabetes mellitus on short-term and long-term outcomes of stage iv colorectal cancer patients after primary surgery: a propensity score matching analysis

Liu,

et al. 2023

Int J Colorectal Dis

View full text Add to dashboard Cite

Metabolic syndrome; associations with adverse outcome after colorectal surgery. A systematic review and meta-analysis

Cited by 8 publications

References 42 publications

Same-Day Discharge After Laparoscopic Roux-en-Y Gastric Bypass: a Cohort of 500 Consecutive Patients

Same-Day Discharge After Laparoscopic Roux-en-Y Gastric Bypass: a Cohort of 500 Consecutive Patients

Influence of metabolic syndrome on prognosis of patients with surgically treated esophageal cancer: a meta-analysis

Impact of type 2 diabetes mellitus on short-term and long-term outcomes of stage iv colorectal cancer patients after primary surgery: a propensity score matching analysis

Contact Info

Product

Resources

About